Biotechnology

Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities at its India Facility

WETTEREN, Belgium, Aug. 13, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a major expansion of small molecule manufacturing capabilities with the addition of a ...

2020-08-13 20:06 2465

CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company

SHANGHAI, Aug. 13, 2020 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SHSE: 688185, HKEX:06185) announced today that it has successfully listed on the Sci-Tech Innovation Board (STAR Market) of the Shanghai Stock Exchange, making it the first "A+ H" dual listing vaccine company. CanSinoB...

2020-08-13 10:00 8294

Innovent and Eli Lilly Announce Acceptance of a Supplemental New Drug Application of TYVYT® (Sintilimab Injection) in Combination with Gemcitabine and Platinum as First-Line Therapy in Squamous Non-Small Cell Lung Cancer in China

SUZHOU, China, Aug. 12, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today joi...

2020-08-12 16:40 6160

ImmunoScape Targets Immunology Breakthroughs for COVID-19 and Oncology with $14.8M (SGD) in Global Financing Led by Anzu Partners and UTEC

The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines SINGAPORE and SAN DIEGO, Aug. 12, 2020 /PRNewswire/ -- ImmunoScape ( www.ImmunoScape.com), a biotech firm enabl...

2020-08-12 08:00 2292

Firmenich Proved its Resilience in a Year of Significant Uncertainty

GENEVA, Aug. 11, 2020 /PRNewswire/ -- Firmenich International SA, the world's largest privately-owned Perfume and Taste company, announced its Full Year Results for the 52 weeks ended30 June 2020.     Financial Highlights * Group revenue reached CHF 3,878m, +2.8% growth on a local currency...

2020-08-11 13:00 2480

AGC Biologics Expands Partnership with Novavax

Manufacturing of Novavax' Matrix-M™Adjuvant for Novel COVID-19 Vaccine Expands toSeattle SEATTLE, Aug. 11, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has expanded its partnership withNovavax, Inc. (NASDA...

2020-08-11 04:20 4916

New Thermo Scientific Selectris Filters Push Cryo-EM Boundaries with Atomic Resolution

Zero-loss energy filters enable life scientists to view protein structures in unprecedented detail HILLSBORO, Oregon, Aug. 11, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today introduced two breakthrough imaging filters, the Thermo Scientific Selectris Im...

2020-08-11 04:17 2282

miR Scientific Announces Validation of its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology

- Validated Data Reinforces Capability to Molecularly Detect and Characterize Prostate Cancer with Concurrent Sensitivity and Specificity of Over 91% - Data Support Integration of Sentinel Prostate Test™ in Patient Care Settings and Decision-Making - Adoption Based on Published Data Indicates Hi...

2020-08-10 19:30 1663

First patient in treatment in RhoVac's clinical phase IIb study in the USA

STOCKHOLM, Aug. 10, 2020 /PRNewswire/ -- The first patient in the USA is included in RhoVac's clinical phase IIb study, called BRaVac. The first US clinic to include a patient in the study was Carolina Urologic Research Center. BraVac is a randomized, placebo controlled and double-blind study, wi...

2020-08-10 16:47 1314

AVATAMED Raises US$1 Million in Seed Funding

SINGAPORE, Aug. 10, 2020 /PRNewswire/ -- AVATAMED, a precision medicine company based inSingapore, announced the completion of its Seed round funding of US$1 million, led by Future Leading Bio Funds, along with other investors. Professor Pierce Chow, Senior Consultant at National Cancer Centre Si...

2020-08-10 15:27 1049

Viva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Escalation of the Service Chain of Innovative Drug Industry

SHANGHAI, Aug. 10, 2020 /PRNewswire/ -- On August 9th, 2020, Viva Biotech ( Shanghai) Co., Ltd. (hereinafter referred to as "Viva Biotech" or "The Company") entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 80% of...

2020-08-10 08:00 1868

Innovent and Lilly Release Clinical Trial Results of Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous NSCLC in an Oral Presentation at IASLC WCLC 2020 Virtual Presidential Symposium

SUZHOU, China, Aug. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today anno...

2020-08-08 21:00 15084

World's First Development and Demonstration of a Quantum Cryptographic Communication Technology Applied System for Genomic Medicine

TOKYO, Aug. 7, 2020 /PRNewswire/ -- Toshiba Corporation (TOKYO: 6502), Tohoku University Tohoku Medical Megabank Organization (ToMMo) and Tohoku University Hospital have demonstrated that quantum cryptographic communications technology can provide genomic medicine with a safe, completely secure d...

2020-08-07 14:00 9103

US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG

SYDNEY, Aug. 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia's paxalis...

2020-08-07 08:30 12782

Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment, Acquires IP From World Leader in Respiratory Disease Medicine

Technology, expertise from UK's Mucokinetica to accelerate repurposing of generic remedy nafamostat for COVID-19 oral, inhalation therapy SAN DIEGO, Aug. 7, 2020 /PRNewswire/ -- A biopharmaceutical company repurposing nafamostat, a generic remedy for pancreatitis and acute kidney injury, is one ...

2020-08-07 01:30 3044

Dietary cholesterol and phytosterols contribute directly to heart disease

Genetic variability in cholesterol and phytosterol absorption affects cardiovascular disease risk REYKJAVIK, Iceland, Aug. 7, 2020 /PRNewswire/ -- Scientists at deCODE genetics , a subsidiary of Amgen, and their collaborators fromthe Icelandic healthcare system, University of Iceland, the Copenha...

2020-08-07 01:21 3972

Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development

Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to announce a new partnership that will offer gl...

2020-08-06 20:10 1139

Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma

SINGAPORE, Aug. 6, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced the publication of results in theJournal of Clinical Oncology

2020-08-06 19:00 2158

Thailand's Eastern Economic Corridor Promotes Genomics Project as Center of Medical Hub

BANGKOK, Aug. 6, 2020 /PRNewswire/ -- Thailand, already famed for its world class hospitals and success combating coronavirus, aims to enhance its role as a global medical hub by establishing a Thailand Genomics Sequencing Center in the country's high-tech Eastern Economic Corridor (EEC), officia...

2020-08-06 18:47 3184

Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine

NEW BRUNSWICK, New Jersey, Aug. 5, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses...

2020-08-05 20:30 4371
12345678 ... 73